ERMA Enorama Pharma AB (publ)

STO · SE · Healthcare · Drug Manufacturers - Specialty & Generic · enorama.se

0.6260SEK-6.57%Mkt Cap: 4.47M $P/E: —Today

Enorama Pharma AB (publ), a pharmaceutical company, develops, manufactures, and sells tobacco-free white snus in Sweden. It offers its products under the NIC-S brand name. The company was incorporated in 2006 and is base…

Industry Peers

Drug Manufacturers - Specialty & Generic

Takeda Pharmaceutical Company Limited

$56.90BUSD

TEVA

Teva Pharmaceutical Industries Limited

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB (publ)

$14.14BUSDP/E 110.6

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated

$11.25BUSD

RDY

Dr. Reddy's Laboratories Limited

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc.

$6.92BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

INDV

Indivior Pharmaceuticals, Inc. - Common Stock

$4.21BUSDP/E 12.8

Key Statistics

Company

Market Cap4.47M USD

Enterprise Value4.58M USD

Revenue (TTM)138.41K USD

Gross Profit-1.44M USD

Net Income (TTM)-7.19M USD

Revenue/Share0.02 SEK

Last Price0.6260 SEK

Fiscal Year EndDec 2025

MR QuarterJun 2026

Employees4

CountrySE

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA-0.88

EV/Revenue33.09

P/S34.54

P/B-0.99

EPS (TTM)-0.81

EPS (Forward)—

52W Range

0.211015% of range3.000

52W High3.000 SEK

52W Low0.2110 SEK

Profitability

Gross Margin-549.22%

Oper. Margin-8708.82%

EBITDA Margin0.00%

Profit Margin-2743.30%

ROE320.41%

ROA-909.45%

Growth

Revenue Growth-81.50%

Earnings Growth—

Cash Flow & Leverage

Operating CF-5.67M USD

CapEx (TTM)—

FCF Margin-1110.09%

FCF Yield-34.40%

Net Debt-200.68K USD

Net Debt/EBITDA0.04

Balance Sheet

Debt/Equity0.00

Current Ratio0.21

Quick Ratio0.12

Book Value/Sh-0.68 SEK

Cash/Share0.03 SEK

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 SEK

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio—

Ex-Div Date—

Pay Date—

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.74.59M

Float60.15M

Insiders91.12%

Institutions1.51%

Technical

SMA 500.6520 (-4.0%)

SMA 2000.6853 (-8.7%)

Beta1.80

S&P 52W Chg14.58%

Avg Vol (30d)155.92K

Avg Vol (10d)13.84K

Technical Indicators

RSI (14)48.4

MACD0.0046

MACD Signal0.0223

MACD Hist.-0.0177

BB Upper0.8206 SEK

BB Middle0.7241 SEK

BB Lower0.6276 SEK

BB Width26.66%

ATR (14)0.1087 SEK

Vol Ratio (20d)0.06x